SYNTEC OPTICS HOLDINGS, INC. quarterly report, Q3 FY2022

Entity and reporting period

Important entity mismatch: The supplied filing is OmniLit Acquisition Corp.’s unaudited Form 10-Q for the quarter ended September 30, 2022—not a filing for Syntec Optics Holdings, Inc. The summary below reflects the filing provided.

OmniLit is a blank-check company seeking a business combination. It had not selected a target, initiated substantive target discussions, or generated operating revenue by September 30, 2022.

Financial results and liquidity

  • Revenue: No operating revenue. Results principally reflect interest earned on trust investments and operating costs.
  • Third quarter 2022: Trust interest income was $662,207; operating costs were $176,931; income before tax was $485,276; income tax expense was $148,386; and net income was $336,890. Basic and diluted earnings per share were $0.02.
  • Nine months ended September 30, 2022: Trust interest income was $882,408; operating costs were $498,094; income tax expense was $154,773; and net income was $229,541. Basic and diluted earnings per share were $0.01.
  • Cash flow: Cash used in operating activities was $437,082 for the nine months. Cash outside the trust account declined to $190,012 from $494,599 at December 31, 2021.
  • Assets and liquidity: Trust-account cash and investments totaled $147.3 million; total assets were $147.7 million. The company reported $364,317 in current assets and $237,473 in current liabilities.
  • Debt and obligations: The company reported no long-term debt. Liabilities included a $5.03 million deferred underwriting discount, payable only if a business combination is completed.
  • Equity: Stockholders’ deficit was $4.56 million. Public shares subject to possible redemption were presented as temporary equity at $146.98 million.

Changes versus prior periods

Third-quarter 2021 results were nil, while third-quarter 2022 net income was $336,890, largely because of interest earned on trust investments. The filing describes no 2021 operating activity or trust investment income for that comparison. Cash outside the trust account fell by $304,587 from year-end 2021 through September 30, 2022. The nine-month 2022 period is not directly comparable with the inception-to-September 2021 period.

Outlook, risks, and unusual items

  • The company said it planned to complete a business combination before its stated February 12, 2023 liquidation deadline. It could seek up to two three-month extensions, to August 12, 2023, subject to board action and sponsor funding. No target had been selected and no substantive target discussions had begun.
  • Management said available working capital and borrowing capacity were expected to meet needs through the earlier of a business combination or one year from the filing. A sponsor commitment letter provided access to up to $100,000 if needed; no funds had been drawn. The sponsor was not obligated to extend the deadline or provide other working-capital loans.
  • Management identified the approaching liquidation deadline as raising substantial doubt about the company’s ability to continue as a going concern if a business combination or extension did not occur. The financial statements were not adjusted for a possible liquidation.
  • The trust account is intended principally to fund a business combination; public shareholders may redeem shares under specified circumstances. If no combination is completed within the permitted period, public shares are to be redeemed and the company liquidated.
  • The filing cites uncertainty from COVID-19 and the Russia-Ukraine conflict, with specific financial impacts not determinable. It also discusses the Inflation Reduction Act’s 1% stock-repurchase excise tax and states that a material impact was not expected based on a preliminary assessment.
  • Management reported effective disclosure controls as of September 30, 2022, no material changes in internal control during the quarter, and no material litigation. No material changes to the previously disclosed risk factors were reported.

Key facts for investors to verify

  • Confirm the issuer: the provided filing identifies OmniLit Acquisition Corp., not Syntec Optics Holdings, Inc.
  • Verify the business-combination status, liquidation deadline, and whether the sponsor funded or approved any extension.
  • Assess the limited cash outside the trust account and the company’s dependence on completing a transaction or obtaining additional financing.
  • Reconcile trust-interest figures: the financial statements report $882,408 for the nine months, while MD&A elsewhere cites $884,088.
  • Review redemption exposure, the $5.03 million deferred underwriting fee, and the sponsor’s ability to meet its stated indemnification obligations.